Pliant Therapeutics (PLRX) Financials: Revenue & Earnings

PLRX price $0.87 +0.01 +1.52%

Ticker
PLRX
Price
$0.87
Change
+0.01 +1.52%
Market cap ?
$53.88M
P/E ?
-0.59
Dividend yield ?
0.00%
Beta ?
1.28
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
57
Quality
46
Growth
100

Stocklytics score rationale: value 57, quality 46, growth 100.

Financials

201720182019202020212022202320242025
00570520004181700075720009685000158000000

Pliant Therapeutics, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to discovering, advancing, and bringing to market innovative therapies for fibrotic and related diseases across the United States. Its flagship investigational product, PLN-74809, is an orally administered, small-molecule, dual-selective inhibitor targeting both avß6 and avß1 integrins, which is currently…

Fair value

PLRX fair value Not meaningful. Price $0.87.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare PLRX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.37——
2026-08-11-0.36-0.34——
2026-05-11-0.32-0.36——
2026-03-11-0.35-0.42—5.00M
2025-11-06-0.43-0.53——
2025-08-07-0.71-0.62——
2025-05-08-0.92-0.78——
2025-03-03-0.82-0.99——
2024-11-07-0.95-0.99—83.33K
2024-08-07-0.92-0.85—490.00K
2024-05-06-0.78-0.76—460.00K
2024-02-27-0.69-0.814.84M814.11K
2023-11-09-0.70-0.78—460.00K
2023-08-09-0.70-0.73248.00K880.00K
2023-05-09-0.67-0.661.33M1.21M
2023-03-09-0.72-0.701.97M1.45M
2022-11-08-0.65-0.741.48M1.79M
2022-08-08-0.82-0.824.99M1.35M
2022-05-09-0.78-0.771.25M1.26M
2022-02-28-0.68-0.762.00M3.00M
2021-11-09-0.75-0.711.61M1.75M
2021-08-09-0.64-0.641.79M1.79M
2021-05-10-0.64-0.592.17M2.03M
2021-03-16-0.54-0.714.46M—
2020-11-10-0.47-1.104.81M—
2020-08-11-1.39-0.773.60M2.60M
2020-06-031.83—57.05M—
2020-03-310.35—28.94M—
2019-09-30-0.58———
2019-06-30-0.68———
2019-03-31-0.61———
2018-03-31-6.88———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-01Raben DavidBuy575.00K$1.05603.75K
2026-09-30Raben DavidOther0——
2026-07-09Iannone RobertOther0——
2026-07-09Iannone RobertBuy60.00K$1.1367.80K
2026-07-09Borellini FlaviaOther0——
2026-07-09Borellini FlaviaBuy60.00K$1.1367.80K
2026-06-11CROWELL GAYLE ABuy70.00K$1.1479.80K
2026-06-11MCCOURT Thomas ABuy70.00K$1.1479.80K
2026-06-11Krognes Steve E.Buy70.00K$1.1479.80K
2026-06-11Curnutte John TBuy70.00K$1.1479.80K
2026-06-11Huh HoyoungBuy70.00K$1.1479.80K
2026-06-11Cline Darren SBuy70.00K$1.1479.80K
2026-04-17Kuo MinnieBuy150.00K$1.33199.50K
2026-04-17Kuo MinnieBuy55.20K$1.3373.42K
2026-04-17Kuo MinnieBuy40.00K$1.3353.20K
2026-04-17Kuo MinnieSell55.20K$11.14614.93K
2026-04-17Kuo MinnieSell150.00K$16.182.43M
2026-04-17Kuo MinnieSell40.00K$17.44697.60K
2026-04-17Cummings Keith LamontBuy124.00K$1.33164.92K
2026-04-17Cummings Keith LamontBuy113.30K$1.33150.69K
2026-04-17Cummings Keith LamontBuy110.50K$1.33146.97K
2026-04-17Cummings Keith LamontBuy76.20K$1.33101.35K
2026-04-17Cummings Keith LamontBuy76.05K$1.33101.14K
2026-04-17Cummings Keith LamontBuy74.25K$1.3398.75K
2026-04-17Cummings Keith LamontBuy18.20K$1.3324.20K
2026-04-17Cummings Keith LamontSell113.30K$11.141.26M
2026-04-17Cummings Keith LamontSell18.20K$6.22113.19K
2026-04-17Cummings Keith LamontSell76.05K$2.08158.18K
2026-04-17Cummings Keith LamontSell74.25K$26.501.97M
2026-04-17Cummings Keith LamontSell124.00K$11.861.47M
2026-04-17Cummings Keith LamontSell76.20K$34.652.64M
2026-04-17Cummings Keith LamontSell110.50K$17.441.93M
2026-04-17Coulie BernardBuy440.00K$1.33585.20K
2026-04-17Coulie BernardBuy327.26K$1.33435.26K
2026-04-17Coulie BernardBuy325.00K$1.33432.25K
2026-04-17Coulie BernardBuy256.30K$1.33340.88K
2026-04-17Coulie BernardBuy250.00K$1.33332.50K
2026-04-17Coulie BernardBuy206.30K$1.33274.38K
2026-04-17Coulie BernardBuy146.84K$1.33195.30K
2026-04-17Coulie BernardSell146.84K$2.08305.43K
2026-04-17Coulie BernardSell327.26K$6.222.04M
2026-04-17Coulie BernardSell250.00K$26.506.62M
2026-04-17Coulie BernardSell440.00K$11.865.22M
2026-04-17Coulie BernardSell206.30K$34.657.15M
2026-04-17Coulie BernardSell256.30K$17.444.47M
2026-04-17Coulie BernardSell325.00K$11.143.62M
2026-04-17Cheung LilyBuy123.00K$1.33163.59K
2026-04-17Cheung LilyBuy52.00K$1.3369.16K
2026-04-17Cheung LilyBuy51.75K$1.3368.83K
2026-04-17Cheung LilySell52.00K$17.44906.88K
2026-04-17Cheung LilySell123.00K$21.932.70M
2026-04-17Cheung LilySell51.75K$11.14576.50K
2026-01-22Cummings Keith LamontBuy400.00K$1.30520.00K
2026-01-22Kuo MinnieBuy300.00K$1.30390.00K
2026-01-22Cheung LilyBuy300.00K$1.30390.00K
2026-01-22Coulie BernardBuy1.23M$1.301.60M
2026-01-20Cummings Keith LamontSell24.00K$1.2830.72K
2026-01-20Cheung LilySell7.53K$1.289.64K
2026-01-20Coulie BernardSell89.38K$1.28114.40K
2026-01-20Kuo MinnieSell6.92K$1.288.85K
2025-12-10Kuo MinnieOther0——
2025-12-10Kuo MinnieOther150.00K$16.182.43M
2025-12-10Kuo MinnieOther40.00K$17.44697.60K
2025-12-10Kuo MinnieOther55.20K$11.14614.93K
2025-06-05Bruhn Suzanne LouiseBuy30.00K$1.6148.30K
2025-06-05Knobil KatharineBuy30.00K$1.6148.30K
2025-06-05MCCOURT Thomas ABuy30.00K$1.6148.30K
2025-06-05Curnutte John TBuy30.00K$1.6148.30K
2025-06-05Krognes Steve E.Buy30.00K$1.6148.30K
2025-06-05Cline Darren SBuy30.00K$1.6148.30K
2025-06-05PYOTT DAVID E IBuy30.00K$1.6148.30K
2025-06-05Huh HoyoungBuy30.00K$1.6148.30K
2025-06-05CROWELL GAYLE ABuy30.00K$1.6148.30K
2025-01-23Cheung LilyBuy51.75K$11.14576.50K
2025-01-23Cheung LilyBuy25.88K——
2025-01-23Ouimette MikeBuy35.00K——
2025-01-23Ouimette MikeBuy70.00K$11.14779.80K
2025-01-23Hull HansBuy40.15K——
2025-01-23Hull HansBuy80.30K$11.14894.54K
2025-01-23Lefebvre EricBuy45.65K——
2025-01-23Lefebvre EricBuy91.30K$11.141.02M
2025-01-23Cummings Keith LamontBuy56.65K——
2025-01-23Cummings Keith LamontBuy113.30K$11.141.26M
2025-01-23Coulie BernardBuy162.50K——
2025-01-23Coulie BernardBuy325.00K$11.143.62M
2025-01-22Ouimette MikeSell10.23K$10.99112.46K
2025-01-17Coulie BernardSell52.42K$11.20587.15K
2025-01-17Cummings Keith LamontSell20.15K$11.20225.68K
2025-01-17Hull HansSell15.94K$11.20178.50K
2025-01-17Lefebvre EricSell18.48K$11.20206.97K
2025-01-17Cheung LilySell3.74K$11.2041.89K
2025-01-17Ouimette MikeSell13.27K$11.20148.64K
2024-07-10Lefebvre EricSell12.32K$11.56142.41K
2024-07-10Hull HansSell9.90K$11.56114.44K
2024-07-10Cummings Keith LamontSell10.91K$11.56126.13K
2024-07-10Coulie BernardSell38.71K$11.56447.49K
2024-07-10Ouimette MikeSell7.66K$11.5688.50K
2024-07-09Lefebvre EricBuy24.06K——
2024-07-09Hull HansBuy19.34K——
2024-07-09Cummings Keith LamontBuy21.31K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 88, holders -6 vs prior quarter. Ownership 77.68%.

HolderSharesChangeChange %Value
TANG CAPITAL MANAGEMENT LLC6.14M-1.87K-0.03%7.00M
ADAR1 CAPITAL MANAGEMENT, LLC5.51M2.92M+113.13%6.28M
VANGUARD CAPITAL MANAGEMENT LLC2.44M97.25K+4.15%2.78M
ACADIAN ASSET MANAGEMENT LLC2.42M00.00%2.75M
TWO SIGMA INVESTMENTS, LP2.26M9.69K+0.43%2.58M
CITADEL ADVISORS LLC2.14M2.11M+5721.27%2.44M
RENAISSANCE TECHNOLOGIES LLC2.05M197.03K+10.63%2.34M
MONACO ASSET MANAGEMENT SAM1.94M00.00%2.21M
LYNX1 CAPITAL MANAGEMENT LP1.80M1.80MNew2.05M
BML CAPITAL MANAGEMENT, LLC1.55M00.00%1.76M
PROSIGHT MANAGEMENT, LP1.37M-297.37K-17.83%1.56M
PEAPOD LANE CAPITAL LLC1.31M20.43K+1.59%1.49M
WOODLINE PARTNERS LP1.30M-370.30K-22.22%1.48M
BLACKROCK, INC.1.15M54.78K+5.00%1.31M
IKARIAN CAPITAL, LLC1.00M1.00MNew1.14M
EVERSEPT PARTNERS, LP891.42K00.00%1.02M
MARSHALL WACE, LLP835.12K-160.85K-16.15%952.04K
REDMILE GROUP, LLC772.13K00.00%880.22K
JPMORGAN CHASE & CO681.65K-180.18K-20.91%783.89K
JACOBS LEVY EQUITY MANAGEMENT, INC643.12K-75.42K-10.50%733.16K
GEODE CAPITAL MANAGEMENT, LLC578.58K161.30K+38.66%659.95K
UBS GROUP AG571.76K-486.19K-45.96%651.81K
MILLENNIUM MANAGEMENT LLC559.45K-621.07K-52.61%637.77K
BRIDGEWAY CAPITAL MANAGEMENT, LLC553.63K00.00%631.14K
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.536.08K18.63K+3.60%611.13K

Earnings and financials

Pliant Therapeutics, Inc. (PLRX) trades at $0.87, with a market cap of $53.88M and a trailing P/E of -0.59. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

201720182019202020212022202320242025
00570520004181700075720009685000158000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Pliant Therapeutics (PLRX) Financials: Revenue & Earnings

PLRX$0.87+0.01 +1.52%

$53.88M

Market Cap

-0.59

P/E

—

Forward P/E

68

Score

Price History